{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:45:29Z","timestamp":1789685129762,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Psych"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40501-016-0076-7","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T04:32:35Z","timestamp":1461299555000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacologic Treatment of Pediatric Anxiety Disorders"],"prefix":"10.1007","volume":"3","author":[{"given":"Farah S.","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Strawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"76_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1207\/s15374424jccp1603_8","volume":"16","author":"CC Strauss","year":"1987","unstructured":"Strauss CC, Frame CL, Forehand R. Psychosocial impairment associated with anxiety in children. J Clin Child Psychol. 1987;16:235\u20139.","journal-title":"J Clin Child Psychol"},{"issue":"10","key":"76_CR2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","volume":"49","author":"KR Merikangas","year":"2010","unstructured":"Merikangas KR, He J-P, Burstein M, Swanson SA, Avenevoli S, Cui L, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication\u2014Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"76_CR3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archgenpsychiatry.2011.160","volume":"69","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry. 2012;69(4):372\u201380.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"76_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/2013.jamapsychiatry.55","volume":"70","author":"MK Nock","year":"2013","unstructured":"Nock MK, Green JG, Hwang I, McLaughlin KA, Sampson NA, Zaslavsky AM, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry. 2013;70(3):300\u201310.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"76_CR5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","volume":"55","author":"DS Pine","year":"1998","unstructured":"Pine DS, Cohen P, Gurley D, Brook J, Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry. 1998;55(1):56\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"76_CR6","doi-asserted-by":"crossref","unstructured":"Brady EU, Kendall PC. Comorbidity of anxiety and depression in children and adolescents. Psychol Bull. 1992;111(2):244-55","DOI":"10.1037\/0033-2909.111.2.244"},{"issue":"3","key":"76_CR7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-7610.1995.tb01300.x","volume":"36","author":"N Ialongo","year":"1995","unstructured":"Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S. The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. J Child Psychol Psychiatry. 1995;36(3):427\u201337.","journal-title":"J Child Psychol Psychiatry"},{"issue":"9","key":"76_CR8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/00004583-200109000-00018","volume":"40","author":"LJ Woodward","year":"2001","unstructured":"Woodward LJ, Fergusson DM. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry. 2001;40(9):1086\u201393.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"76_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/104454604773840544","volume":"14","author":"AK Langley","year":"2004","unstructured":"Langley AK, Bergman RL, McCracken J, Piacentini JC. Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version. J Child Adolesc Psychopharmacol. 2004;14(1):105\u201314.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"76_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00004583-200402000-00019","volume":"43","author":"D Bastiaansen","year":"2004","unstructured":"Bastiaansen D, Koot HM, Ferdinand RF, Verhulst FC. Quality of life in children with psychiatric disorders: self-, parent, and clinician report. J Am Acad Child Adolesc Psychiatry. 2004;43(2):221\u201330.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"76_CR11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1176\/appi.ajp.162.6.1171","volume":"162","author":"MH Rapaport","year":"2005","unstructured":"Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162:1171\u20138.","journal-title":"Am J Psychiatry"},{"key":"76_CR12","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","volume":"359","author":"JT Walkup","year":"2008","unstructured":"Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359:2753\u201366.","journal-title":"N Engl J Med"},{"issue":"4","key":"76_CR13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","volume":"42","author":"B Birmaher","year":"2003","unstructured":"Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, et al. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2003;42(4):415\u201323.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"76_CR14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaac.2015.01.008","volume":"54","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, et al. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(4):283\u201393. This study represents a recent double-blind placebo-controlled study of youth with GAD and summarizes the data that was considered as part of the recent FDA approval of duloxetine for pediatric patients with GAD.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"76_CR15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266\u201377.","journal-title":"Am J Psychiatry"},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biopsych.2007.02.025","volume":"62","author":"JS March","year":"2007","unstructured":"March JS, Entusah AR, Rynn M, Albano AM, Tourian KA. A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry. 2007;62:1149\u201354.","journal-title":"Biol Psychiatry"},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","volume":"61","author":"KD Wagner","year":"2004","unstructured":"Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry. 2004;61:1153\u201362.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"76_CR18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hup.2361","volume":"28","author":"X Huang","year":"2013","unstructured":"Huang X, Li C, Li W, Luo Y, Wang B, Zhang W, et al. Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open\u2010label trial. Hum Psychopharmacol Clin Exp. 2013;28(6):594\u20139.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-4-1","volume":"4","author":"SN Compton","year":"2010","unstructured":"Compton SN, Walkup JT, Albano AM, Piacentini JC, Birmaher B, Sherrill JT, et al. Child\/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods. Child Adolesc Psychiatr Ment Health. 2010;4:1.","journal-title":"Child Adolesc Psychiatr Ment Health"},{"key":"76_CR20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","volume":"344","author":"DS Pine","year":"2001","unstructured":"Pine DS, Walkup JT, Labellarte MJ, Riddle MA, Greenhill L, Klein R, et al. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med. 2001;344:1279\u201385.","journal-title":"N Engl J Med"},{"issue":"10","key":"76_CR21","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/01.chi.0000231974.43966.6e","volume":"45","author":"GS Ginsburg","year":"2006","unstructured":"Ginsburg GS, Riddle MA, Davies M. Somatic symptoms in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1179\u201387.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"76_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/cap.1997.7.17","volume":"7","author":"JM Fairbanks","year":"1997","unstructured":"Fairbanks JM, Pine DS, Tancer NK, Dummit III ES, Kentgen LM, Martin J, et al. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol. 1997;7:17\u201329.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"76_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004583-199201000-00006","volume":"31","author":"JG Simeon","year":"1992","unstructured":"Simeon JG, Ferguson HB, Knott V, Roberts N, Gauthier B, Dubois C, et al. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry. 1992;31(1):29\u201333.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"76_CR24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004583-199403000-00011","volume":"33","author":"F Graae","year":"1994","unstructured":"Graae F, Milner J, Rizzotto L, Klein RG. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 1994;33(3):372\u20136.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"76_CR25","doi-asserted-by":"crossref","unstructured":"Strawn J, Compton S, Robertson B, Albano A, Hamdani M, Rynn M. Guanfacine extended-release in pediatric anxiety disorders: a randomized, placebo-controlled trial. Annual Meeting of the Anxiety and Depression Association of America, Philadelphia, PA. 2016.","DOI":"10.1089\/cap.2016.0132"},{"issue":"2","key":"76_CR26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/104454601750284054","volume":"11","author":"G Masi","year":"2001","unstructured":"Masi G, Toni C, Mucci M, Millepiedi S, Mata B, Perugi G. Paroxetine in child and adolescent outpatients with panic disorder. J Child Adolesc Psychopharmacol. 2001;11(2):151\u20137.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"76_CR27","volume-title":"Paroxetine: safety and tolerability issues","author":"DM Marks","year":"2008","unstructured":"Marks DM, Park M-H, Ham B-J, Han C, Patkar AA, Masand PS, et al. Paroxetine: safety and tolerability issues. London: Informa UK Ltd; 2008."},{"issue":"2","key":"76_CR28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.chi.0000246070.23695.06","volume":"46","author":"SD Connolly","year":"2007","unstructured":"Connolly SD, Bernstein GA. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(2):267\u201383.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"76_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11920-015-0591-z","volume":"17","author":"AM Wehry","year":"2015","unstructured":"Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR. Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep. 2015;17(7):52.","journal-title":"Curr Psychiatry Rep"},{"key":"76_CR30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1037\/a0025933","volume":"79","author":"GS Ginsburg","year":"2011","unstructured":"Ginsburg GS, Kendall PC, Sakolsky D, Compton SN, Piacentini J, Albano AM, et al. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol. 2011;79:806\u201313.","journal-title":"J Consult Clin Psychol"},{"key":"76_CR31","doi-asserted-by":"crossref","unstructured":"Gonzalez A, Peris TS, Vreeland A, Kiff CJ, Kendall PC, Compton SN, et al. Parental anxiety as a predictor of medication and CBT response for anxious youth. Child Psychiatry Hum Dev. 2014.","DOI":"10.1007\/s10578-014-0454-6"},{"issue":"3","key":"76_CR32","first-page":"310","volume":"71","author":"SN Compton","year":"2014","unstructured":"Compton SN, Peris TS, Almirall D, Birmaher B, Sherrill J, Kendall PC, et al. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. J Consult Clin Psychol. 2014;71(3):310\u20138. This is a thorough review of clinical and demographic factors which influence treatment reponse in pediatric patients with anxiety disorders.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"76_CR33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/cap.2012.0007","volume":"22","author":"G Masi","year":"2012","unstructured":"Masi G, Pfanner C, Mucci M, Berloffa S, Magaz\u00f9 A, Parolin G, et al. Pediatric social anxiety disorder: predictors of response to pharmacological treatment. J Child Adolesc Psychopharmacol. 2012;22(6):410\u20134.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"76_CR34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/da.22329","volume":"32","author":"JR Strawn","year":"2015","unstructured":"Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015;32(3):149\u201357. This is currently the only meta-analysis of antidepressants in youth with non-OCD anxiety disorders and suggests a moderate effect size and a favorable tolerability profile","journal-title":"Depress Anxiety"},{"issue":"7","key":"76_CR35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.2014.13101337","volume":"171","author":"J Mohatt","year":"2014","unstructured":"Mohatt J, Bennett SM, Walkup JT. Treatment of separation, generalized, and social anxiety disorders in youths. Am J Psychiatry. 2014;171(7):741\u20138.","journal-title":"Am J Psychiatry"}],"container-title":["Current Treatment Options in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-016-0076-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40501-016-0076-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-016-0076-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T23:12:05Z","timestamp":1567811525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40501-016-0076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s40501-016-0076-7","relation":{},"ISSN":["2196-3061"],"issn-type":[{"value":"2196-3061","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}